Suspension of trading

Valuation Forte Biosciences

Stocks

Market Closed - Nasdaq 04:00:00 27/08/2026 HKT			5-day change	1st Jan Change
76.99 ^USD	+0.03%		+0.09%	+182.32%

08-28	Argenx SE completed the acquisition of Forte Biosciences, Inc..	CI
08-27	Argenx Completes Acquisition of Forte Biosciences	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	31.57	21	29.86	145.2	486.3	1,939	-	-
Change	-	-33.49%	42.17%	386.3%	234.91%	298.77%	-	-
Enterprise Value (EV)	31.57	21	29.86	145.2	486.3	1,939	1,939	1,939
Change	-	-33.49%	42.17%	386.3%	234.91%	298.77%	0%	0%
P/E	-1.38x	-1.25x	-	-1.87x	-5.79x	-17.2x	-18.9x	-18.5x
PBR	-	-	-	-	-	-	-	-
PEG	-	0x	-	-	0.1x	3.52x	2.09x	-7.94x
Capitalization / Revenue	-	-	-	-	-	-	-	-
EV / Revenue	-	-	-	-	-	-	-	-
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-	-	-	-0x	-0x	-21.3x	-18.1x	-15.2x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-38.75	-20	-	-12.17	-4.71	-4.48	-4.075	-4.17
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-	-	-	-36.6	-70.66	-91.11	-107.4	-127.6
Net income ¹	-21.71	-13.88	-	-35.48	-69.38	-91.11	-107.4	-127.6
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	53.50	25.00	20.54	22.71	27.27	76.99	76.99	76.99
Nbr of stocks (in thousands)	590	840	1,453	6,393	17,831	25,186	-	-
Announcement Date	31/3/22	31/3/23	18/3/24	28/3/25	31/3/26	-	-	-